פעילות
-
Happy to share our most recent paper on immune response to lipid nanoparticles. We started the project 10 years ago (!!), kicked off by Lisa…
Happy to share our most recent paper on immune response to lipid nanoparticles. We started the project 10 years ago (!!), kicked off by Lisa…
נוסף לייק על ידי Ilan Oren
-
Exciting times in Neuropsychiatry, with novel mechanism of actions emerging. Muscarinic receptor agonism is one of them, bringing hope for people…
Exciting times in Neuropsychiatry, with novel mechanism of actions emerging. Muscarinic receptor agonism is one of them, bringing hope for people…
נוסף לייק על ידי Ilan Oren
-
Clexio Biosciences is attending and presenting at the 7th Neuropsychiatric Drug Development summit (September 24-26, Boston, MA) I'm excited to…
Clexio Biosciences is attending and presenting at the 7th Neuropsychiatric Drug Development summit (September 24-26, Boston, MA) I'm excited to…
נוסף לייק על ידי Ilan Oren
עוד פעילות על ידי Ilan
-
We’ve expanded our leadership team with the appointment of Kriya’s Scientific Co-Founder, J Fraser Wright, PhD, as Chief Gene Therapy Officer to…
We’ve expanded our leadership team with the appointment of Kriya’s Scientific Co-Founder, J Fraser Wright, PhD, as Chief Gene Therapy Officer to…
נוסף לייק על ידי Ilan Oren
-
So proud of Roivant, celebrating its 10-year anniversary today. Founded it in May 2014 to challenge the old pharma model & change the game. A decade…
So proud of Roivant, celebrating its 10-year anniversary today. Founded it in May 2014 to challenge the old pharma model & change the game. A decade…
נוסף לייק על ידי Ilan Oren
-
We are proud to announce the FDA acceptance and priority review of our new drug application (NDA) filing for our investigational therapy for…
We are proud to announce the FDA acceptance and priority review of our new drug application (NDA) filing for our investigational therapy for…
נוסף לייק על ידי Ilan Oren
-
Today we announced an update on our pipeline progress in advance of our presentation on January 9th at the JP Morgan conference. Looking forward to a…
Today we announced an update on our pipeline progress in advance of our presentation on January 9th at the JP Morgan conference. Looking forward to a…
נוסף לייק על ידי Ilan Oren
-
We are excited to publicly unveil our gene therapy program for Thyroid Eye Disease! Thank you to our entire team for the tremendous work in advancing…
We are excited to publicly unveil our gene therapy program for Thyroid Eye Disease! Thank you to our entire team for the tremendous work in advancing…
נוסף לייק על ידי Ilan Oren
-
Matthew Gline: "We have our existing pipeline, which is still in our view the most exciting I&I pipeline in biotech – we think we have a best in…
Matthew Gline: "We have our existing pipeline, which is still in our view the most exciting I&I pipeline in biotech – we think we have a best in…
נוסף לייק על ידי Ilan Oren
-
https://lnkd.in/eggRdUC4
https://lnkd.in/eggRdUC4
נוסף לייק על ידי Ilan Oren
-
Roche Enters Into a Definitive Agreement to Acquire Telavant Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of…
Roche Enters Into a Definitive Agreement to Acquire Telavant Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of…
נוסף לייק על ידי Ilan Oren
-
We are excited to announce our acquisition of Tramontane Therapeutics. We believe that gene therapy can play an important role in the treatment of…
We are excited to announce our acquisition of Tramontane Therapeutics. We believe that gene therapy can play an important role in the treatment of…
נוסף לייק על ידי Ilan Oren
-
I am incredibly proud of our team and grateful to our amazing group of investors. We believe that gene therapy will transform the entire field of…
I am incredibly proud of our team and grateful to our amazing group of investors. We believe that gene therapy will transform the entire field of…
נוסף לייק על ידי Ilan Oren
-
🎉Now available for over 100M patients in urgent care centers in the US!!! MeMed BV cleared by the FDA to distinguish between bacterial and viral…
🎉Now available for over 100M patients in urgent care centers in the US!!! MeMed BV cleared by the FDA to distinguish between bacterial and viral…
נוסף לייק על ידי Ilan Oren
-
Clexio is Hiring! We are looking for our next Head of Preclinical Development. As the Head of Preclinical Development, this individual will oversee…
Clexio is Hiring! We are looking for our next Head of Preclinical Development. As the Head of Preclinical Development, this individual will oversee…
נוסף לייק על ידי Ilan Oren
-
We recently celebrated a meaningful milestone here at Roivant - 10 positive Phase 3 trials since 2019. We feel incredibly privileged to have worked…
We recently celebrated a meaningful milestone here at Roivant - 10 positive Phase 3 trials since 2019. We feel incredibly privileged to have worked…
נוסף לייק על ידי Ilan Oren
-
Roivant announced exciting results today for patients with ulcerative colitis demonstrating improvement in efficacy from the induction to chronic…
Roivant announced exciting results today for patients with ulcerative colitis demonstrating improvement in efficacy from the induction to chronic…
נוסף לייק על ידי Ilan Oren
פרופילים דומים אחרים
שמות אחרים Ilan Oren ב Israel
-
Ilan Oren
Founder & Executive Director at Men of the Match Football Agency
-
Ilan Ben-Oren
-
Ilan Oren
H.W Design Engineer, Tech Team Leader
-
Ilan Oren
OREN @ Co. at OREN & Co.
4 Ilan Oren שמות אחרים מופיעים Israel ב-לינקדאין
הצג/י אנשים אחרים בשם Ilan Oren